🎗️ EASL Liver Cancer Summit 2026 📅 22–24 January 📍 Edinburgh, UK ✨ Session highlight: explore the latest technologies transforming our understanding of hepatocellular carcinoma, including single-cell sequencing, spatial transcriptomics, the gut–liver microbiome axis, and the

Are you looking to grow your skills and connect with peers across Europe? Do you want to advance your research in liver disease? 🔍 Discover our two fellowship types and apply by this Monday, 1 September 2025! 🔗 https://t.co/zcmmdkcq53 #LiverTwitter #LiverX

🧩The EASL #SLDSummit 2026 (26–28 February, Budapest) will bring together experts and early-career researchers to explore the latest in steatotic liver disease, from prevention and diagnostics to innovative therapies and patient care. 🔎 Don’t miss the opening session: The

Today is #WorldHepatitisDay! We spotlight two DECISION partners deeply committed to #liverhealth: 🔬 @EASLnews – advancing #hepatology research 🧡 @EuropeLiver – amplifying the voice of liver patients Together, we work toward a healthier future beyond ACLF. #Cirrhosis

🌍 More than 1 million lives are lost each year to viral hepatitis — and the number is still rising. But with early testing, diagnosis and care, we can change the trajectory. 🦠 Over 250 million people live with chronic hepatitis B. It’s a leading cause of cirrhosis and liver

📢Today EASL celebrates #WorldHepatitisDay 2025 and the @hep_alliance campaign “Let’s break it down”! Listen to an EASL Policy Dialogue where two expert voices came together to unpack the urgent challenge of hepatitis and the bold initiatives driving its elimination. In this

🚨 Alcohol is still hiding in plain sight as one of Europe's biggest public health threats. 🍺 1 in 4 deaths among young Europeans is caused by alcohol. 🚫 Yet we have proven tools to prevent this. At #EASLCongress 2025, @WHO_Europe and EASL launched the European Health Alliance

🍷🚫The European Health Alliance on Alcohol (EHAA), representing 1.2 million health professionals across Europe, has submitted a formal letter of support for Ireland’s alcohol labelling regulations, set to take effect in May 2026. This evidence-based policy is critical for

👇👇👇👇👇👇👇👇 The @EASLedu Fellowships are back! We look forward to hearing from you 👂Please do apply.

Last chance to apply for the EASL-@AASLDtweets Masterclass! This is a key opportunity to sharpen your leadership, communication & career skills! From mentorship to publishing, negotiation to networking — prepare to thrive in academic & clinical life. ❗Application deadline: this

You asked for more time to complete your application for the EASL–AASLD Masterclass 2025 — and we’re giving it to you. 🗓️ The new deadline is 13 July 2025! Take this extra time to perfect your application and get ready for an unforgettable learning experience! 🔗

📢 New in The Lancet Gastroenterology & Hepatology: a timely and urgent opinion piece calls on European policymakers to confront the continent’s unsustainable burden of alcohol-related harms. 🔍 The article features the European Health Alliance on Alcohol, launched during

🚨Starting now!🚨 🔦Spotlight on patient stories, public misconceptions, and bold policy solutions from across Europe in the next episode of #EASLStudio 📍Onsite: Hepatology Arena 💻Online: : https://t.co/AJTVxr4d2c @AleksanderKrag @sanidadgob @hazelreporting @WHO_Europe

🛑 Stigma stops care. It's time to end it. EASL’s newly released #PolicyStatement is a powerful Call to Action: Everyone deserves dignity, respect, and access to liver care, free from blame and discrimination. Stigma around liver diseases like hepatitis, ArLD, and MASLD

🍺🍷🚫EASL will mark a significant milestone in alcohol harm reduction and public health advocacy with a series of high-level activities on 7–8 May during #EASLCongress 2025. ⭐️ 🌷7 May, 10:30 - 11:30 CEST Opening Ceremony: “Turning Evidence into Action: Tackling Alcohol-Related

🚴‍♂️ One of EASL’s own — a member of our Policy, Public Health, and Advocacy Committee — is cycling from Leeds to Amsterdam for #EASLCongress 2025! 🌍 Steatotic Liver Disease is the most common liver disease in Europe and is characterised by a build-up of fat in the liver. Simple

🍷🚫EASL will spotlight alcohol harm reduction at #EASLCongress 2025 with key events on 7–8 May, in collaboration with @WHO_Europe The Opening Ceremony on 7 May will feature public health leaders from Spain, Estonia, and WHO Europe. 🌷 On the same day, the #EASLStudio session

🇮🇪 EASL supports Ireland’s alcohol health warning labelling regulations 🍷🏷️EASL urges the Irish Prime Minister to Defend Alcohol Labelling Laws. We warn against industry pressure to delay or weaken the rules, which aim to inform consumers about the health risks of alcohol,

This week's #EASLStudio episode is now available on demand. Catch up on this interactive discussion around alcohol policy implementations now: https://t.co/tKYENEnntC @SagiZelber @DebbieShawcros1 #LiverX #LiverTwitter

@SagiZelber @DebbieShawcros1 @WHO_Europe @AleksanderKrag @ThomasBerg24 @EASLnews Although socially acceptable, alcohol has become social & health issue. 🍹🍷Just 2 drinks/week 👉1:1000 chance of premature death! @EASLNews #LiverTwitter #LiverX #EASLStudio